<DOC>
	<DOCNO>NCT00166452</DOCNO>
	<brief_summary>The purpose study determine lenalidomide safe effective treatment complex regional pain syndrome type 1 ( CRPS ) .</brief_summary>
	<brief_title>A Study Effect Lenalidamide Complex Regional Pain Syndrome Type 1</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Somatoform Disorders</mesh_term>
	<mesh_term>Complex Regional Pain Syndromes</mesh_term>
	<mesh_term>Reflex Sympathetic Dystrophy</mesh_term>
	<criteria>1 . Age &gt; = 18 year 2 . Signed consent form 3 . A diagnosis CRPS type I least oneyear duration unilateral involvement distal limb 4 . CRPS pain intensity score least 4 11point PINRS 5 . Measurable sural , median sensory , median motor peroneal motor nerve conduction 6 . Women childbearing potential must negative serum urine pregnancy test within 7 day start study drug . They must agree use adequate contraceptive method include steroidbased contraceptive . They must also agree pregnancy test every 4 week study drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>